Matic Earns KLAS Research Recognition as Leading Innovator in AI Medical Documentation
Matic, a pioneering AI-native clinical intelligence platform, has garnered attention from KLAS Research, being named an Emerging Company for its flagship product, Scribematic®. This recognition underscores Matic’s commitment to enhancing medical documentation accuracy and customization while significantly improving clinical workflows.
DALLAS, Jan. 27, 2026 /PRNewswire-PRWeb/ — The KLAS Emerging Company Spotlight for 2026 has acknowledged Matic’s impactful innovations in AI-driven medical documentation. Scribematic® delivers measurable enhancements in documentation efficiency, provider satisfaction, and support for clinical workflows, allowing healthcare providers to concentrate more on patient care.
KLAS Research, a highly respected authority in healthcare IT insights, highlighted Scribematic for its capability to generate customizable and precise medical notes. Feedback from users revealed substantial improvements in documentation quality, notable time savings, and reduced clinician burnout. Remarkably, 100% of the respondents indicated they would choose Matic’s solutions again, emphasizing the platform’s effectiveness and close alignment with real clinical settings.
Mac Boyter, Senior Research Director at KLAS Research, stated, “This report validates Scribematic’s performance, showing that clinicians achieve improved outcomes and organizations realize significant financial benefits. The efficiency and workflow optimization reported by operational leaders further confirm Matic’s essential value in delivering high-quality healthcare at reduced costs.”
Key highlights from customer feedback include:
– Timely support and a dedicated team committed to client satisfaction
– High reliability and alignment of the product with clinical workflows
– Effective integration capabilities that meet customer needs
– Recognition of overall solution quality and transparency in pricing
– Positive user experiences and a strong intention to continue utilizing Matic’s solutions
KLAS identified Scribematic’s efficiency improvements and its responsive vendor support as decisive advantages in complex healthcare environments, showcasing Matic’s approach to creating tailored AI solutions that work seamlessly within existing systems.
Matic’s CEO, Calvin Carter, emphasized, “Unlike many AI Scribe vendors that offer a single solution, Matic provides an integrated suite of purpose-built tools, supported by a proactive implementation team. Our focus is not only on deployment but on delivering measurable outcomes for healthcare providers.”
Respondents from the KLAS survey noted that Scribematic aids in same-day chart closure, enhances accuracy, and fosters stronger physician-patient engagement, all integral to Matic’s clinician-first design philosophy that seeks to alleviate administrative burdens.
Scribematic, along with Matic’s broader suite of agentic AI solutions, is crafted to optimize the full spectrum of clinical documentation and care processes. The platform intelligently adapts to specialty-specific requirements and supports seamless integration into electronic health record (EHR) systems, ultimately streamlining operations and improving patient outcomes.
With a focus on continuous improvement and customer engagement, Matic is promising to remain at the forefront of clinical AI innovation. As the healthcare landscape evolves, solutions like Scribematic pave the way for enhanced documentation practices, ultimately leading to better patient care.
For more information about Matic’s offerings, visit www.maticinside.ai.
About KLAS Research: KLAS provides accurate and impartial insights to improve healthcare decision-making, helping organizations identify vendor performance through direct provider feedback. More details can be found at https://engage.klasresearch.com/.
